Evidence map›Paper›PMID 28822085›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2019

Nuclear imaging of cardiac amyloidosis.

Efstathia Andrikopoulou, Pradeep Bhambhvani

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Quantitation of myocardialJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  2. Cardiac amyloidosis detection by early bisphosphonate (99mTc-HMDP) scintigraphy.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  3. Article
  4. Review
  5. Review
  6. Deep-learning-based cardiac amyloidosis classification from early acquired pet images.The international journal of cardiovascular imaging · 2021
    Article
  7. Article
  8. The current status of quantitative SPECT/CT in the assessment of transthyretin cardiac amyloidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  9. The evolving landscape of nuclear imaging in cardiac amyloidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  10. Article
  11. Novel Approaches for the Management of AL Amyloidosis.Current hematologic malignancy reports · 2018
    Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Efstathia AndrikopoulouDivision of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA. eandrikopoulou@bwh.harvard.edu.
Pradeep BhambhvaniDivision of Molecular Imaging and Therapeutics, Department of Radiology, The University of Alabama at Birmingham, 619 19th Street South, Birmingham, AL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmyloidosisPrealbuminDiphosphonatesHumansRadionuclide ImagingDiphosphonatesPrealbumin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.